These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7021384)

  • 1. Determination of 24-hour insulin infusion pattern by an artificial endocrine pancreas for intravenous insulin infusion with a miniature pump.
    Kølendorf K; Christiansen JS; Bojsen J; Svendsen PA; Teglbjaerg LL
    Horm Metab Res; 1981 May; 13(5):245-9. PubMed ID: 7021384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A portable, pre-programmable insulin infusion system in diabetes mellitus.
    Kølendorf K; Bojsen J
    Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic studies during normoglycaemic clamping of insulin-dependent diabetics using a glucose-controlled insulin infusion system.
    Nattrass M; Alberti KG; Buckle AL; Cluett B; Jaspan JB; Noy GA; Stubbs WA; Walton R
    Horm Metab Res Suppl; 1979; (8):86-92. PubMed ID: 395096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J; Selam JL; Pham TC; Orsetti A
    Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of glucose homeostasis in insulin-dependent diabetics using a miniature insulin infusion pump with a fixed profile.
    Køolendorf K; Bojsen J; Løorup B
    Diabetologia; 1980; 18(2):141-5. PubMed ID: 6988273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
    Froesch ER; Blatter G; Morell B
    Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A portable infusion pump, programmable with 16 rates.
    Bojsen J; Kølendorf K; Haslev F; Jørgensen K
    Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose clamping using the Biostator GCIIS.
    Verdonk CA; Rizza RA; Westland RE; Nelson RL; Gerich JE; Service FJ
    Horm Metab Res; 1980 Apr; 12(4):133-5. PubMed ID: 6993319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of an artificial B-cell in clinic and experimental medicine].
    Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ
    Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin responses to mixed meals: comparison of an artificial beta cell and normal beta cells.
    Horwitz DL
    Horm Metab Res Suppl; 1979; (8):68-71. PubMed ID: 395093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of an artifical pancreas and portable pumps in the treatment of juvenile diabetes].
    Buysschaert M; Lambotte L; Lambert AE
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():35-46. PubMed ID: 6995675
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion.
    Calabrese G; Bueti A; Zega G; Giombolini A; Bellomo G; Antonella MA; Massi-Benedetti M; Brunetti P
    Horm Metab Res; 1982 Oct; 14(10):505-7. PubMed ID: 6757081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a glucose-controlled insulin infusion system in children and adolescents with insulin-dependent diabetes.
    Golden MP; Myers GL; Tanner SM; Marrero DG; Charles MA
    Pediatrics; 1982 Jul; 70(1):36-42. PubMed ID: 7088631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.